← Evidence map

ArticleHuman genetics2026

Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.

Michiel Vlaming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42667419